Hudson Bay Capital Management LP - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$52,353,594
+126.2%
1,468,544
+192.7%
0.21%
+22.6%
Q2 2023$23,146,742
-42.1%
501,772
-49.7%
0.17%
-4.0%
Q1 2023$39,973,204
+52.4%
996,838
+76.1%
0.18%
-34.7%
Q4 2022$26,222,780
+86.3%
566,000
+66.5%
0.27%
+114.4%
Q3 2022$14,079,000
+159.3%
340,000
+273.6%
0.12%
+204.9%
Q2 2022$5,429,000
+120.2%
91,000
+203.3%
0.04%
+10.8%
Q3 2020$2,466,000
-76.6%
30,000
-77.8%
0.04%
-80.0%
Q2 2020$10,559,000
+1.7%
135,000
-42.2%
0.18%
-28.8%
Q1 2020$10,384,000
-16.2%
233,706
-19.4%
0.26%
-5.8%
Q4 2019$12,386,000
+86.8%
290,000
+87.1%
0.28%
+50.8%
Q3 2019$6,631,000
-5.1%
155,000
+40.9%
0.18%
+14.4%
Q2 2019$6,985,000
-8.5%
110,0000.0%0.16%
+63.3%
Q1 2019$7,630,000
+75.5%
110,000
+10.0%
0.10%
+69.0%
Q4 2018$4,348,000
-28.9%
100,000
-16.7%
0.06%
-54.3%
Q1 2018$6,119,000
+31.9%
120,000
+20.0%
0.13%
+27.0%
Q4 2017$4,638,000100,0000.10%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2022
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders